VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
Brambles Limited vs Roche Holding AG
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Brambles Limited
BXB · ASX
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Brambles Limited's moat claims, evidence, and risks.
View BXB analysisRoche Holding AG
ROG · SIX Swiss Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Roche Holding AG's moat claims, evidence, and risks.
View ROG analysisComparison highlights
- Moat score gap: Brambles Limited leads (71 / 100 vs 68 / 100 for Roche Holding AG).
- Segment focus: Brambles Limited has 3 segments (55% in CHEP Americas); Roche Holding AG has 2 segments (76.3% in Pharmaceuticals).
- Primary market structure: Oligopoly vs Competitive. Pricing power: Moderate vs Moderate.
- Moat breadth: Brambles Limited has 4 moat types across 3 domains; Roche Holding AG has 5 across 3.
Primary market context
Brambles Limited
CHEP Americas
Pallet pooling and reusable transport packaging pooling services
Americas (North America and Latin America)
Manufacturers, producers/growers, retailers, and logistics partners
Pooling asset owner/operator and service provider
55%
Roche Holding AG
Pharmaceuticals
Innovative (branded) prescription pharmaceuticals
Global
Healthcare providers and systems (hospitals/clinics), payers/governments, and patients
Innovator pharmaceutical developer, manufacturer and marketer
76.3%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Brambles Limited strengths
Roche Holding AG strengths
Segment mix
Brambles Limited segments
Full profile >CHEP Americas
Oligopoly
CHEP EMEA
Oligopoly
CHEP Asia-Pacific
Oligopoly
Roche Holding AG segments
Full profile >Pharmaceuticals
Competitive
Diagnostics
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.